2026 Clinical Trials Conference Agenda
8:30 to 9 a.m.
Registration and Refreshments
Morning Session
9 to 9:20 a.m.
Opening Remarks
Dr. Alycia Marshall
President, Community College of Philadelphia
Dr. Alycia Marshall
President, Community College of Philadelphia
9:25 to 9:55 a.m.
Keynote Speaker: Dr. Hossein Borghaei, Fox Chase Cancer Center
Dr. Borghaei serves as the Chief of Thoracic Medical Oncology and Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, and the Gloria and Edmund M. Dunn Chair in Thoracic Malignancies.
Dr. Borghaei serves as the Chief of Thoracic Medical Oncology and Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, and the Gloria and Edmund M. Dunn Chair in Thoracic Malignancies.
10 to 10:20 a.m.
Speaker: Dr. Naseem D. S. Kerr, University of Pennsylvania
Dr. Kerr is the Director of Clinical Research Operations in the Department of Neurology at University of Pennsylvania's Perelman School of Medicine.
Dr. Kerr is the Director of Clinical Research Operations in the Department of Neurology at University of Pennsylvania's Perelman School of Medicine.
10:25 to 10:35 a.m.
Break
10:40 to 11 a.m.
Speaker: Dr. Janet Lee, Temple University
Dr. Lee is the Assistant Dean for Clinical Research, Adolescent Medicine, and Associate Professor of Pediatrics at the Lewis Katz School of Medicine at Temple University.
Dr. Lee is the Assistant Dean for Clinical Research, Adolescent Medicine, and Associate Professor of Pediatrics at the Lewis Katz School of Medicine at Temple University.
11:55 a.m. to 12:15 p.m.
Panel and Discussion
12:15 to 1:25 p.m.
Lunch, Survey
12:35 to 1:25 p.m.
Education & Job Fair (Winnet Lobby, Ground Floor)
Afternoon Session
1:30 to 2 p.m.
Keynote Speaker: Kathleen OMalley RN, BSN, CCRP, Thomas Jefferson University
Ms. OMalley is the Director of Education and Training at Thomas Jefferson University's Jefferson Clinical Research Institute.
Ms. OMalley is the Director of Education and Training at Thomas Jefferson University's Jefferson Clinical Research Institute.
2:05 to 2:25 p.m.
Speaker: Katherine Taylor, MBA, ACRP-CP, Merck
Ms. Taylor is the Head of Emerging Talent for Global Clinical Trial Operations at Merck.
Ms. Taylor is the Head of Emerging Talent for Global Clinical Trial Operations at Merck.
2:30 to 2:50 p.m.
Speaker: Leila Cupersmith, Choice ClinOps
Ms. Cupersmith is the Founder and CEO of Choice ClinOps, a cancer and rare disease clinical trial operations partner, fractional and consulting.
Ms. Cupersmith is the Founder and CEO of Choice ClinOps, a cancer and rare disease clinical trial operations partner, fractional and consulting.
2:55 to 3:05 p.m.
Break
3:10 to 3:30 p.m.
Speaker: Dr. Babar Bashir, MD, MS, Thomas Jefferson University
Dr. Bashir is the Associate Professor of Medical Oncology, Associate Professor of Pharmacology, Physiology, and Cancer Biology at Thomas Jefferson University.
Dr. Bashir is the Associate Professor of Medical Oncology, Associate Professor of Pharmacology, Physiology, and Cancer Biology at Thomas Jefferson University.
3:35 to 3:55 p.m.
Speaker: Cecilia (CJ) Torres, Thomas Jefferson University
Ms. Torres is the Clinical Research Coordinator in the Medical Oncology/Division of Population Science at Thomas Jefferson University, and a CCP alum.
Ms. Torres is the Clinical Research Coordinator in the Medical Oncology/Division of Population Science at Thomas Jefferson University, and a CCP alum.
4 to 4:20 p.m.
Panel and Discussion
4:25 to 5 p.m.
Closing Remarks, Survey